Stay updated on KarMMa Clinical Trial: bb2121 in RRMM
Sign up to get notified when there's something new on the KarMMa Clinical Trial: bb2121 in RRMM page.

Latest updates to the KarMMa Clinical Trial: bb2121 in RRMM page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record for the Phase 2 bb2121 trial in relapsed or refractory multiple myeloma is now available, with detailed trial information and supporting documents and links.SummaryDifference83%

- Check18 days agoChange DetectedThe footer revision label on the 403 Forbidden page changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide NIH notice announces updates to NIH websites and says “Super Intelligence” is replacing “Artificial Intelligence” in some federal agency content during the transition.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s site revision changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer’s site revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check45 days agoChange DetectedThe study page displays a 403 Forbidden message instead of study information, with a Home link.SummaryDifference0.5%

Stay in the know with updates to KarMMa Clinical Trial: bb2121 in RRMM
Enter your email address, and we'll notify you when there's something new on the KarMMa Clinical Trial: bb2121 in RRMM page.